Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruthy Shaco-Levy
Daniel Benharroch

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Scientific Reports|March 30, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney diseaseDaniel Landau, Jannat Khalilia, Eden Arazi, et al.
Molecules (Basel, Switzerland)|April 9, 2020
Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles VirusHila Winer, Janet Ozer, Yonat Shemer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
IL-1 is required for tumor invasiveness and angiogenesisElena Voronov, Dror S Shouval, Yakov Krelin, et al.
International Immunology|July 4, 2008
Contribution of IL-1 to resistance to Streptococcus pneumoniae infectionDaniel Kafka, Eduard Ling, Galia Feldman, et al.
The Journal of Investigative Dermatology|November 2, 2007
Expression of ligands to NKp46 in benign and malignant melanocytesEmanuela Cagnano, Oren Hershkovitz, Alon Zilka, et al.
International Journal of Molecular Sciences|May 13, 2023
In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i> on Cells and K18-<i>hACE2</i> Mice Infected with SARS-CoV-2Shay Weiss, Kamran Waidha, Saravanakumar Rajendran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasivenessXiaoping Song, Elena Voronov, Tatyana Dvorkin, et al.
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Plos One|May 5, 2015
Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Nature Medicine|August 8, 2006
Decidual NK cells regulate key developmental processes at the human fetal-maternal interfaceJacob Hanna, Debra Goldman-Wohl, Yaron Hamani, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Scientific Reports|March 30, 2024
A Nuphar lutea plant active ingredient, 6,6'-dihydroxythiobinupharidine, ameliorates kidney damage and inflammation in a mouse model of chronic kidney diseaseDaniel Landau, Jannat Khalilia, Eden Arazi, et al.
Molecules (Basel, Switzerland)|April 9, 2020
Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles VirusHila Winer, Janet Ozer, Yonat Shemer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2003
IL-1 is required for tumor invasiveness and angiogenesisElena Voronov, Dror S Shouval, Yakov Krelin, et al.
International Immunology|July 4, 2008
Contribution of IL-1 to resistance to Streptococcus pneumoniae infectionDaniel Kafka, Eduard Ling, Galia Feldman, et al.
The Journal of Investigative Dermatology|November 2, 2007
Expression of ligands to NKp46 in benign and malignant melanocytesEmanuela Cagnano, Oren Hershkovitz, Alon Zilka, et al.
International Journal of Molecular Sciences|May 13, 2023
In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i> on Cells and K18-<i>hACE2</i> Mice Infected with SARS-CoV-2Shay Weiss, Kamran Waidha, Saravanakumar Rajendran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasivenessXiaoping Song, Elena Voronov, Tatyana Dvorkin, et al.
Plos One|May 15, 2008
Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Plos One|May 5, 2015
Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapyTal I Arnon, Gal Markel, Ahuva Bar-Ilan, et al.
Nature Medicine|August 8, 2006
Decidual NK cells regulate key developmental processes at the human fetal-maternal interfaceJacob Hanna, Debra Goldman-Wohl, Yaron Hamani, et al.
Pageof 13